More good news came out of Israel on Saturday when the country’s health ministry released another round of data on the Pfizer-BioNTech COVID-19 vaccine, further affirming its effectiveness.
The latest numbers, which were compiled through Feb. 13 and compare the vaccinated and unvaccinated populations, show that the jab has been nearly 96 percent effective at preventing symptomatic COVID-19 infections two weeks after individuals receive their second dose. When it comes to preventing severe infections, hospitalizations, and deaths from the coronavirus, the figure jumps to an efficacy rate around 99 percent.
Israel’s Ministry of Health says benefits of #PfizerVaccine 14 days after 2jab are:
• 95.8% preventing illness cases
• 98.0% preventing fever and/or respiratory symptoms
• 98.9% preventing hospitalization
• 99.2% preventing severe illness
• 98.9% preventing death
— Noa Landau נעה לנדאו (@noa_landau) February 20, 2021
Israel has emerged as the world’s clearest case study for determining whether the Pfizer vaccine works, since the country has the highest vaccination rate in the world. So far, the data has been consistently promising, though the situation is still fluid and under observation.